Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition - Fierce Biotech

As reported by FierceBiotech

Telix has struck a deal to buy ITM Isotope Technologies Munich | Telix has struck a deal to buy ITM Isotope Technologies Munich for $1.65 billion upfront, securing an R&D pipeline led by a rival to Novartis’ Lutathera and a radiopharmaceutical supply network.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on FierceBiotech ↗

Market Samachar is a news aggregator. This article was originally published by FierceBiotech. Tap the button above to read the full story on their site.

COMPANIES Fortis audit order could drag listed firms into promoters' personal debt cases: InGovern Stocks-Markets-Economic Times
COMPANIES After Hindenburg: 5 Adani group companies settle disclosure violation case with Sebi Stocks-Markets-Economic Times
INDIAN LG Electronics launches new range of Semi-Automatic Washing Machines Share Market Today
INDIAN Hikal commences commercial production of its personal care products Share Market Today
INDIAN FSL recognized among Best in 'Services Eating Software' at the 2026 HFS SaS Awards Share Market Today
INDIAN RNIT AI Solutions secures engagement with APSSDC Share Market Today
INDIAN Varmora Granito IPO subscribed 11% Share Market Today
INDIAN Sunil Singhania-led Abakkus files for IPO, issue to be entirely an OFS Share Market Today

Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition - Fierce Biotech

More from Market Samachar